Brief: Argent Biopharma Seeks Trading Halt
28/06/2024 02:21
June 28 (Reuters) - Argent BioPharma Ltd RGT.AX :
* SEEKS TRADING HALT PENDING RELEASE OF AN ANNOUNCEMENT
REGARDING
A CAPITAL RAISING
Source text for Eikon: ID:nASX8wjllM
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program